Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Total Liabilities (2024 - 2025)

Bioharvest Sciences has reported Total Liabilities over the past 2 years, most recently at $22.2 million for Q4 2025.

  • For Q4 2025, Total Liabilities changed N/A year-over-year to $22.2 million; the TTM value through Dec 2025 reached $22.2 million, changed N/A, while the annual FY2025 figure was $22.2 million, N/A changed from the prior year.
  • Total Liabilities was $22.2 million for Q4 2025 at Bioharvest Sciences, down from $27.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $32.0 million in Q2 2025 and bottomed at $20.3 million in Q2 2024.